> Pasireotide may decrease the relative bioavailability of CICLOSPORIN. Concomitant adm inistration of pasireotide and CICLOSPORIN may require adjustment of the CICLOSPORIN dose to maintain therapeutic levels .
> Insulin and antidiabetic medicinal products  Dose adjustments (decrease or increase) of insulin an d antidiabetic medicinal products (e.g. METFORMIN, LIRAGLUTIDE, VILDAGLIPTIN, NATEGLINIDE) may be required when administered concomitantly with pasireotide (see also section  4.4).
